Skip to main content

SQZ Biotechnologies Co

SQZDelisted Jul 19, 2023
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001604477

SQZ Biotechnologies Co was delisted on Jul 19, 2023; its insiders filed their last Form 4 on Jun 15, 2023; 31 institutions reported holding it in 13F filings for Q2 2023, worth $2.96M in total; Maverick Capital was the only superinvestor holding it.

Q3 2023 vs. Q2 2023

How the institutions holding SQZ Biotechnologies Co changed between Q2 2023 and Q3 2023.

All holders in Q3 2023All holders in Q2 2023

13F holders of SQZ: Q2 2023 compared with Q3 2023
MeasureQ2 2023Q3 2023Change
Holders315−26
Shares11.0M4.14M−6.83M (−62.2%)
Value$2.96M$333.1K−$2.63M (−88.8%)

New holders (0)

Institutions that held SQZ Biotechnologies Co at the end of Q3 2023 but not at the end of Q2 2023.

None.

Sold out (26)

Institutions that held SQZ Biotechnologies Co at the end of Q2 2023 and filed for Q3 2023 without it.

Institutions that sold out of SQZ in Q3 2023
InstitutionShares, Q2 2023Value, Q2 2023
Temasek Holdings (Private) Ltd2,758,169$744.7K
Maverick Capital LtdSuperinvestorMaverick Capital1,050,286$283.6K
Vanguard Group Inc941,086$254.1K
Stifel Financial Corp851,520$229.9K
Laurion Capital Management LP412,865$111.5K
Geode Capital Management, LLC135,360$36.5K
Renaissance Technologies LLC83,603$23.0K
Millennium Management LLC80,938$21.9K
RBF Capital, LLC74,674$20.2K
Bridgeway Capital Management, LLC65,800$17.8K
BlackRock Inc.64,677$17.5K
State Street Corp56,140$15.2K
Sandy Cove Advisors, LLC51,707$14.0K
SG Americas Securities, LLC43,420$12.0K
Prudential Financial Inc40,200$10.9K
Northern Trust Corp31,022$8.38K
Susquehanna International Group, LLP29,231$7.89K
Morgan Stanley17,135$4.63K
Goldman Sachs Group Inc15,896$4.29K
HSBC Holdings PLC11,440$3.11K
Tower Research Capital LLC (TRC)6,368$1.72K
UBS Group AG1,410$381
Bank of America Corp1,268$342
Wells Fargo & Company140$38
Federation des caisses Desjardins du Quebec105$28
Royal Bank of Canada646$0